Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 1
2004 5
2005 3
2006 10
2007 10
2008 20
2009 8
2010 14
2011 14
2012 14
2013 14
2014 25
2015 22
2016 24
2017 32
2018 26
2019 49
2020 67
2021 78
2022 63
2023 84
2024 32

Text availability

Article attribute

Article type

Publication date

Search Results

551 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of tislelizumab plus lenvatinib as first-line treatment in patients with unresectable hepatocellular carcinoma: a multicenter, single-arm, phase 2 trial.
Xu L, Chen J, Liu C, Song X, Zhang Y, Zhao H, Yan S, Jia W, Wu Z, Guo Y, Yang J, Gong W, Ma Y, Yang X, Gao Z, Zhang N, Zheng X, Li M, Su D, Chen M. Xu L, et al. Among authors: zhao h. BMC Med. 2024 Apr 23;22(1):172. doi: 10.1186/s12916-024-03356-5. BMC Med. 2024. PMID: 38650037 Free PMC article. Clinical Trial.
The superior detection rate of total-body [68Ga]Ga-PSMA-11 PET/CT compared to short axial field-of-view [68Ga]Ga-PSMA-11 PET/CT for early recurrent prostate cancer patients with PSA < 0.2 ng/mL after radical prostatectomy.
Wang Y, Dong L, Zhao H, Li L, Huang G, Xue W, Liu J, Chen R. Wang Y, et al. Among authors: zhao h. Eur J Nucl Med Mol Imaging. 2024 Mar 22. doi: 10.1007/s00259-024-06674-1. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 38514483
551 results